Related references
Note: Only part of the references are listed.Development of synthetic microRNA-214 showing enhanced cytotoxicity and RNase resistance for treatment of canine hemangiosarcoma
Ryutaro Yoshikawa et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2020)
Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines
Takashi Miwa et al.
IN VIVO (2019)
Molecular Imaging of Mesothelin-Expressing Ovarian Cancer with a Human and Mouse Cross-Reactive Nanobody
Andrew M. Prantner et al.
MOLECULAR PHARMACEUTICS (2018)
Synthesis and properties of 4′-C-aminoalkyl-2′-fluoro-modified RNA oligomers
Toshifumi Kano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
miR-214: a potential biomarker and therapeutic for different cancers
Tanu Sharma et al.
FUTURE ONCOLOGY (2015)
Diagnosis of a large splenic tumor in a dog: computed tomography versus magnetic resonance imaging
Mijin Kim et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2015)
MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis
Kazuki Heishima et al.
PLOS ONE (2015)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines
Atsuko Murai et al.
BMC VETERINARY RESEARCH (2012)
MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release
Alain van Mil et al.
CARDIOVASCULAR RESEARCH (2012)
Development of Double-Stranded siRNA Labeling Method Using Positron Emitter and Its In Vivo Trafficking Analyzed by Positron Emission Tomography
Kentaro Hatanaka et al.
BIOCONJUGATE CHEMISTRY (2010)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Share Paper
